<DOC>
	<DOCNO>NCT01927263</DOCNO>
	<brief_summary>The purpose study investigate similarity NI-071 infliximab ( comparator ) term efficacy patient Rheumatoid Arthritis adequately respond Methotrexate .</brief_summary>
	<brief_title>A Phase 3 Study NI-071 Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>1 . Patients diagnosis RA define American College Rheumatology ( ACR ) European League Against Rheumatism ( EULAR ) criterion ( ACR/EULAR 2010 ) 2 . Patients receive MTX treatment ( 6 16mg/week ) 2 week least 12 week prior screen visit 1 . Patients follow past History concomitant diseases Other Connective tissue disorder may interfere efficacy assessment Chronic recurrent infectious disease Demyelinating disease Congestive heart failure lymphoproliferative disorder myelodysplastic syndrome Malignancy Interstitial lung disease 2 . Patients active latent tuberculosis history tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>